查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529756

细胞分析市场规模、份额和趋势分析报告：按产品/服务、方法、流程、最终用途、地区和细分市场进行预测，2024-2030 年

Cell Analysis Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Consumables, Instruments), By Technique (Flow Cytometry, PCR), By Process, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

细胞分析市场规模和趋势

2023年全球细胞分析市场规模预估为292亿美元，2024年至2030年复合年增长率预估为9.8%。这种增长归因于慢性病盛行率的增加、细胞分析技术的进步以及药物发现活动的增加。细胞分析已成为识别慢性病潜在治疗方法和治疗方法的重要工具。因此，心血管疾病、癌症、自体免疫疾病和神经系统疾病等慢性疾病的盛行率不断上升可能会推动细胞分析的需求。据美国癌症协会称，预计 2024 年美国将诊断出超过 200 万个新癌症病例。

细胞分析在肿瘤学领域越来越受欢迎，其应用范围不断扩大，从早期癌症诊断到癌症相关治疗方法和工具的开发。肿瘤学领域的公司正在加紧努力推进细胞分析，以开发先进的治疗方法和疗法。例如，2024 年 3 月，癌症诊断公司 Serum Detect 计划在美国癌症研究协会 (AACR) 上展示其用于早期癌症检测的 T 细胞分析方法。医疗公司为扩大细胞分析应用所做的努力预计将在预测期内推动市场成长。

此外，细胞分析技术的进步促进了自动化细胞分析系统的发展，该系统能够提供更准确、更有效率的结果。同样，自动细胞成像、细胞计数和细胞分选仪等先进技术的发展使研究人员能够更大规模地研究细胞。例如，NanoCellect Biomedical 宣布推出其影像引导细胞分类机VERLO。细胞分选仪使研究人员能够区分和分选相互作用的细胞，从而能够精确表征细胞亚群并检验其功能表型，而不会干扰细胞相互作用。细胞分析技术的此类进步预计将在预测期内增加需求并推动市场成长。

除此之外，在药物发现中越来越多地采用细胞週期分析来分析所涉及的复杂性。同样，细胞生物学、分子生物学、生物资讯学、蛋白质组学和基因组学的进步正在增加在药物开发过程中利用基于细胞的测定的重要性。基于细胞的检测提供了传统毒性和药物安全测试方法的替代方法，使研究人员能够透过细胞毒性或细胞死亡的早期筛检来识别测试化合物的问题。因此，由于对先进治疗的需求不断增长，药物发现活动的增加预计将增加对基于细胞的检测的需求，从而推动市场成长。

全球细胞分析市场报告细分

该报告预测了全球、区域和国家层面的收益成长，并对2018年至2030年各子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research, Inc. 根据产品和服务、技术、製程、最终用途和地区对全球细胞分析市场报告进行了细分。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 细胞分析市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 细胞分析市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第 4 章 细胞分析市场：产品与服务、估算与趋势分析

  • 细分仪表板
  • 全球细胞分析市场产品与服务波动分析
  • 2018-2030年全球细胞分析材料市场规模与趋势分析（依产品及服务）
  • 试剂/耗材
  • 装置
  • 配件
  • 软体
  • 服务

第五章细胞分析市场：技术、估计与趋势分析

  • 细分仪表板
  • 全球细胞分析市场技术波动分析
  • 2018-2030年全球细胞分析材料市场规模及趋势分析（依技术）
  • 流式细胞技术
  • PCR
  • 细胞微阵列
  • 显微镜检查
  • 光强度
  • 高内涵筛检
  • 其他的

第六章 细胞分析材料市场：过程、估计与趋势分析

  • 细分仪表板
  • 全球细胞分析市场的製程变迁分析
  • 2018-2030 年全球细胞分析市场规模与趋势分析（按流程）
  • 细胞识别
  • 细胞活力
  • 细胞讯息途径
  • 细胞增殖
  • 细胞计数
  • 细胞交互作用
  • 细胞结构研究
  • 单细胞分析
  • 其他的

第七章 细胞分析市场：最终用途、估算与趋势分析

  • 细分仪表板
  • 全球细胞分析市场的最终用途变化分析
  • 2018-2030 年全球细胞分析市场规模与趋势分析（依最终用途）
  • 製药和生物技术公司
  • 医院和临床试验实验室
  • 学术研究所
  • 其他的

第八章细胞分析市场：区域估计和趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • BD
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Miltenyl Biotech
    • Revvity
    • New England Biolabs
    • Avantor, Inc.
Product Code: GVR-4-68040-348-7

Cell Analysis Market Size & Trends

The global cell analysis market size was estimated at USD 29.2 billion in 2023 and is projected to grow at a CAGR of 9.8% from 2024 to 2030. This growth can be attributed to the increasing prevalence of chronic diseases, advancements in cell analysis technologies, and the growing number of drug discovery activities. Cell analysis has emerged as an important tool for the identification of potential therapies and treatments for chronic diseases. Thus, the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, autoimmune diseases, neurological disorders, and others can drive the demand for cell analysis. According to the American Cancer Society, over 2 million new cancer cases are expected to be diagnosed in the U.S. in 2024.

Cell analysis has witnessed an increase in its application, from early-stage cancer diagnostics to the development of cancer-associated therapies and tools, which has further increased its popularity in the oncology sector. The players operating in the oncology sector are increasing their efforts for advancements in cell analysis to develop advanced therapies and treatments. For instance, in March 2024, a cancer diagnostics company, Serum Detect, was set to launch the T-cell analysis approach for early cancer detection at the American Association for Cancer Research (AACR). Such increasing efforts by healthcare companies to increase the application of cell analysis are anticipated to drive market growth over the forecast period.

Moreover, technological advancements in cell analysis have enabled the development of automated cell analysis systems that offer results with better accuracy and efficiency. Similarly, the development of advanced technologies such as automated cell imaging, cell counting, and cell sorters allows researchers to study cells on a much larger scale. For instance, in July 2024. NanoCellect Biomedical announced the launch of VERLO, an image-guided cell sorter. This cell-sorter allows the researchers to distinguish & sort interacting cells, enabling precise characterization of cell subsets & validation of their functional phenotypes without disturbing the cell interactions. Such advancements in cell analysis technologies are anticipated to increase demand and drive market growth over the forecast period.

In addition to this, the adoption of cell cycle analysis has significantly increased in drug discovery to analyze the associated complexities. Similarly, the increasing advancements in cell biology, molecular biology, bioinformatics, proteomics, and genomics have increased the significance of utilizing cell-based assays in the drug development process. Cell-based assays offer an alternative approach to the conventional methods of toxicity and drug safety testing and allow researchers to identify problems with tested compounds in early screening through cytotoxicity and cell deaths. Thus, the increasing drug discovery activities owing to the rising need for advanced treatments are anticipated to increase the demand for cell-based assays, thereby driving the market growth.

Global Cell Analysis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cell analysis market report based on product & service, technique, process, End-use, and region.

  • Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Reagents & Consumables
  • Instruments
  • Accessories
  • Software
  • Service
  • Technique Outlook (Revenue, USD Million, 2018 - 2030)
  • Flow Cytometry
  • PCR
  • Cell Microarrays
  • Microscopy
  • Spectrophotometry
  • High Content-Screening
  • Other Techniques
  • Process Outlook (Revenue, USD Million, 2018 - 2030)
  • Cell Identification
  • Cell Viability
  • Cell Signaling Pathways
  • Cell Proliferation
  • Cell Counting
  • Cell Interaction
  • Cell Structure Study
  • Single-cell Analysis
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinical Testing Laboratories
  • Academic & Research Institutes
  • Other
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • MEA

South Africa

Saudi Arabia

UAE

Kuwait

    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Cell Analysis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Advancements in cell analysis technologies
      • 3.2.1.3. Growing number of drug discovery activities
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Complexity of cell analysis techniques
  • 3.3. Cell Analysis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Analysis Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell Analysis Market Product & Service Movement Analysis
  • 4.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Reagents & Consumables
    • 4.4.1. Reagents & Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Accessories
    • 4.6.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Software
    • 4.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Service
    • 4.8.1. Service market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cell Analysis Market: Technique Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell Analysis Market Technique Movement Analysis
  • 5.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 5.4. Flow Cytometry
    • 5.4.1. Flow Cytometry market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. PCR
    • 5.5.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Cell Microarrays
    • 5.6.1. Cell Microarrays market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Microscopy
    • 5.7.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Spectrophotometry
    • 5.8.1. Spectrophotometry market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. High Content-Screening
    • 5.9.1. High Content-Screening market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Other Techniques
    • 5.10.1. Other Techniques market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cell Analysis Materials Market: Process Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cellular Starting Materials Market Process Movement Analysis
  • 6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Process, 2018 to 2030 (USD Million)
  • 6.4. Cell Identification
    • 6.4.1. Cell Identification market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Cell Viability
    • 6.5.1. Cell Viability market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Cell Signaling Pathways
    • 6.6.1. Cell Signaling Pathwaysmarket estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Cell Proliferation
    • 6.7.1. Cell Proliferation market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Cell Counting
    • 6.8.1. Cell Counting market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Cell Interaction
    • 6.9.1. Cell Interaction market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Cell Structure Study
    • 6.10.1. Cell Structure Study market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.11. Single-cell Analysis
    • 6.11.1. Single-cell Analysis market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.12. Others
    • 6.12.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cellular Starting Materials Market: End use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Cellular Starting Materials Market End use Movement Analysis
  • 7.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Hospitals & Clinical Testing Laboratories
    • 7.5.1. Hospitals & Clinical Testing Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Other
    • 7.7.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cell Analysis Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. Target disease prevalence
      • 8.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Target disease prevalence
      • 8.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Target disease prevalence
      • 8.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. Target disease prevalence
      • 8.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Target disease prevalence
      • 8.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Target disease prevalence
      • 8.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Target disease prevalence
      • 8.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Target disease prevalence
      • 8.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Target disease prevalence
      • 8.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Target disease prevalence
      • 8.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Target disease prevalence
      • 8.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Target disease prevalence
      • 8.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Target disease prevalence
      • 8.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Target disease prevalence
      • 8.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Target disease prevalence
      • 8.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Target disease prevalence
      • 8.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Target disease prevalence
      • 8.6.6.4. Regulatory framework
      • 8.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Target disease prevalence
      • 8.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Target disease prevalence
      • 8.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. Target disease prevalence
      • 8.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. Target disease prevalence
      • 8.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. Target disease prevalence
      • 8.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Target disease prevalence
      • 8.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Danaher
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. BD
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Merck KGaA
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Agilent Technologies, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Bio-Rad Laboratories, Inc.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Miltenyl Biotech
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Revvity
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. New England Biolabs
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Avantor, Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cell analysis market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 5 Global cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 6 Global cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 7 North America cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 10 North America cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 11 North America cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 12 U.S. cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 13 U.S. cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 14 U.S. cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 15 U.S. cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 16 Canada cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 17 Canada cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 18 Canada cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 19 Canada cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 20 Mexico cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Mexico cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 22 Mexico cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 23 Mexico cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 24 Europe cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Europe cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 27 Europe cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 28 Europe cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 29 Germany cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 30 Germany cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 31 Germany cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 32 Germany cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 33 UK cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 UK cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 35 UK cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 36 UK cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 37 France cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 38 France cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 39 France cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 40 France cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 41 Italy cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Italy cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 43 Italy cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 44 Italy cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 45 Spain cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Spain cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 47 Spain cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 48 Spain cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 49 Denmark cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Denmark cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 51 Denmark cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 52 Denmark cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 53 Sweden cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 54 Sweden cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 55 Sweden cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 56 Sweden cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 57 Norway cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 58 Norway cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 59 Norway cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 60 Norway cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 66 China cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 China cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 68 China cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 69 China cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 70 Japan cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 71 Japan cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 72 Japan cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 73 Japan cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 74 India cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 India cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 76 India cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 77 India cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 78 South Korea cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 79 South Korea cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 80 South Korea cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 81 South Korea cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 82 Australia cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 83 Australia cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 84 Australia cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 85 Australia cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 86 Thailand cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 Thailand cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 88 Thailand cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 89 Thailand cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 90 Latin America cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 92 Latin America cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 93 Latin America cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 94 Latin America cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 95 Brazil cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 96 Brazil cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 97 Brazil cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 98 Brazil cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 99 Argentina cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 100 Argentina cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 101 Argentina cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 102 Argentina cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 103 MEA cell analysis market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 105 MEA cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 106 MEA cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 107 MEA cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 108 South Africa cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 109 South Africa cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 110 South Africa cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 111 South Africa cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 116 UAE cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 117 UAE cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 118 UAE cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 119 UAE cell analysis market, by End use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait cell analysis market, by product & service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait cell analysis market, by technique, 2018 - 2030 (USD Million)
  • Table 122 Kuwait cell analysis market, by process, 2018 - 2030 (USD Million)
  • Table 123 Kuwait cell analysis market, by End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Cell Analysis market: Market outlook
  • Fig. 5 Cell Analysis market: Segment outlook
  • Fig. 6 Cell Analysis market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Cell Analysis market driver impact
  • Fig. 9 Cell Analysis market restraint impact
  • Fig. 10 Cell Analysis market: Product & Service outlook and key takeaways
  • Fig. 11 Cell Analysis market: Product & Service movement analysis
  • Fig. 12 Reagents & consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Software market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Service market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Cell Analysis market: Technique outlook and key takeaways
  • Fig. 18 Cell Analysis market: Technique movement analysis
  • Fig. 19 Flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Cell microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Microscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Spectrophotometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 High content-screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Other techniques market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Cell Analysis market: Process outlook and key takeaways
  • Fig. 27 Cell Analysis market: Process movement analysis
  • Fig. 28 Cell identification market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Cell viability market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Cell Signaling Pathwaysmarket estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Cell proliferation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cell counting market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Cell interaction market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Cell structure study market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Cell Analysis market: End use outlook and key takeaways
  • Fig. 38 Cell Analysis market: End use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Hospitals & clinical testing laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Global Cell Analysis market: Regional outlook and key takeaways
  • Fig. 44 Global Cell Analysis market: Regional movement analysis
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Target Disease Prevalence
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Target Disease Prevalence
  • Fig. 52 Key country dynamics
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Target Disease Prevalence
  • Fig. 55 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Target Disease Prevalence
  • Fig. 59 Key country dynamics
  • Fig. 60 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Target Disease Prevalence
  • Fig. 62 Key country dynamics
  • Fig. 63 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Target Disease Prevalence
  • Fig. 65 Key country dynamics
  • Fig. 66 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Target Disease Prevalence
  • Fig. 68 Key country dynamics
  • Fig. 69 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Target Disease Prevalence
  • Fig. 71 Key country dynamics
  • Fig. 72 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Target Disease Prevalence
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Target Disease Prevalence
  • Fig. 77 Key country dynamics
  • Fig. 78 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Target Disease Prevalence
  • Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Target Disease Prevalence
  • Fig. 84 Key country dynamics
  • Fig. 85 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Target Disease Prevalence
  • Fig. 87 Key country dynamics
  • Fig. 88 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Target Disease Prevalence
  • Fig. 90 Key country dynamics
  • Fig. 91 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Target Disease Prevalence
  • Fig. 93 Key country dynamics
  • Fig. 94 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Target Disease Prevalence
  • Fig. 96 Key country dynamics
  • Fig. 97 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Target Disease Prevalence
  • Fig. 99 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Target Disease Prevalence
  • Fig. 103 Key country dynamics
  • Fig. 104 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Target Disease Prevalence
  • Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Target Disease Prevalence
  • Fig. 110 Key country dynamics
  • Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Target Disease Prevalence
  • Fig. 113 Key country dynamics
  • Fig. 114 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Target Disease Prevalence
  • Fig. 116 Key country dynamics
  • Fig. 117 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 118 Target Disease Prevalence